And interestingly, INF and MTX combination therapy reduced the Ca2+ concentration significantly by blocking the TRPM2 channel, which makes INF and MTX useful antagonists of neutrophil apoptosis and mitochondrial oxidative stress in RA patients. This evidence concerns the gene CBLIF and rheumatoid arthritis.